Skip to main content
Clinical Trials/NCT05085678
NCT05085678
Completed
N/A

Development and Evaluation of a PROMs-based Interactive Programme as a Supporting Tool for Breast Cancer Patients Using Adjuvant Endocrine Therapy

Universitaire Ziekenhuizen KU Leuven1 site in 1 country77 target enrollmentDecember 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
77
Locations
1
Primary Endpoint
Change in quality of Life - FACT-ES - B5 - H18
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The objective of the study is to evaluate the effect of an online tool, based on patient reported outcomes (Co'moon), on the quality of life of breast cancer patients on adjuvant endocrine therapy in the University Hospital Leuven.

Detailed Description

The project aims to develop and evaluate an online programme to support patients with breast cancer on adjuvant endocrine therapy in the University Hospital Leuven. The tool "Co'moon" has been developed in the first phase of the project and secondly refine in a pilot study. In the third phase a randomised controlled study investigates the effect of Co'moon in comparison with the standard of care in the University Hospital Leuven. Hereby focussing on the improvement of self-efficacy en quality of life.

Registry
clinicaltrials.gov
Start Date
December 1, 2020
End Date
December 31, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in quality of Life - FACT-ES - B5 - H18

Time Frame: monthly after two months of AET; up to 3 months

Total score of Functional Assessment of Chronic Illness Therapy system of Quality of Life questionnaires of endocrine symptoms (FACT-ES) combined with additional questions B5 and H18. A validated questionnaire with a 5-point Likert scale and a total score of 180 (high QoL).

Change in self-efficacy

Time Frame: month 3 and 6 or 7 after the start with AET

patient reported impact on the side effects of AET

Therapy adherence

Time Frame: monthly after two months of AET; up to 3 months

patient reported intentional or accidental forgot the medication

Questionnaire on patients experience with the patient-physician relationship

Time Frame: month 6 or 7 after the start with AET

patient reported their experience of the follow-up consultation in a 5 point Likert scale questionnaire

Questionnaire on change in patient-relative communication over a period of +/- 3 months

Time Frame: month 3 and 6 or 7 after the start with AET

patient reported a change in the communication of patients with their relatives in a 5 point Likert scale questionnaire

Secondary Outcomes

  • Patient reported outcomes(Monthly after two months of AET; up to 3 months)
  • Questionnaire on the experience of the healthcare professional regarding the summary of PRO's(month 6 or 7 after the start of AET)
  • Time-spend on Co'moon(up to 3 months)

Study Sites (1)

Loading locations...

Similar Trials